Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 29,923 shares at $53.26 ($1.6M) on 2024-10-16, disclosed to the SEC on 2024-10-16.
Scheduled sale ($1.6M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.74 | 9,923 | $533K | 33.3% |
| 2 | $53.74 | 9,923 | $533K | 33.3% |
| 3 | $54.25 | 77 | $4K | 0.3% |
| 4 | $53.26 | 10,000 | $533K | 33.2% |
| Total | $53.58 avg | 29,923 | $1.6M | 100% |
| Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |
| HALO | SELL | 2024-06-20 | $494K | — | Filing → |